Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$2.2 million.

  • NeuroPace's Net Cash Flow fell 18618.37% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 728.97%. This contributed to the annual value of -$4.6 million for FY2024, which is 14040.86% down from last year.
  • As of Q3 2025, NeuroPace's Net Cash Flow stood at -$2.2 million, which was down 18618.37% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Net Cash Flow ranged from a high of $17.1 million in Q2 2021 and a low of -$12.5 million during Q1 2021
  • In the last 5 years, NeuroPace's Net Cash Flow had a median value of -$154000.0 in 2024 and averaged -$317894.7.
  • Per our database at Business Quant, NeuroPace's Net Cash Flow skyrocketed by 522571.43% in 2023 and then crashed by 457787.61% in 2024.
  • NeuroPace's Net Cash Flow (Quarter) stood at -$7.4 million in 2021, then surged by 111.9% to $886000.0 in 2022, then soared by 845.94% to $8.4 million in 2023, then tumbled by 123.15% to -$1.9 million in 2024, then dropped by 12.22% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$4.2 million for Q2 2025, and $13.6 million during Q1 2025.